Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davidson

Showing results (41-50 of 358) with videos related to

Pageof 36
Sort By:
International Journal of Food Microbiology|December 16, 2003
Enhancement of nisin, lysozyme, and monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and lactoferrinJill K Branen, P Michael Davidson
Expert Review of Cardiovascular Therapy|September 27, 2005
Torcetrapib/atorvastatin combination therapyHarold Bays, James McKenney, Michael Davidson
Trends in Cardiovascular Medicine|August 15, 2009
The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitusTamar Polonsky, Theodore Mazzone, Michael Davidson
Journal of Food Protection|March 7, 2013
Antimicrobial activity of nanodispersed thymol in tryptic soy brothBhavini Shah, P Michael Davidson, Qixin Zhong
International Journal of Food Microbiology|December 25, 2012
Nanodispersed eugenol has improved antimicrobial activity against Escherichia coli O157:H7 and Listeria monocytogenes in bovine milkBhavini Shah, P Michael Davidson, Qixin Zhong
Applied and Environmental Microbiology|October 2, 2012
Nanocapsular dispersion of thymol for enhanced dispersibility and increased antimicrobial effectiveness against Escherichia coli O157:H7 and Listeria monocytogenes in model food systemsBhavini Shah, P Michael Davidson, Qixin Zhong
Journal of Clinical Lipidology|March 6, 2012
Polish Lipid Association--a strong response to the problem of lipid disorders in Poland and Central and Eastern EuropeMaciej Banach, Michael Davidson, Peter P Toth
Dialogues in Clinical Neuroscience|October 29, 2011
Treatment-refractory schizophreniaAsaf Caspi, Michael Davidson, Carol A Tamminga
Dialogues in Clinical Neuroscience|October 29, 2011
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?Ramit Ravona-Springer, Michael Davidson, Shlomo Noy
Oncotargets and Therapy|August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinomaMichael Davidson, Elizabeth C Smyth, David Cunningham
Pageof 36

Showing results (41-50 of 358) with videos related to

Sort By:
Pageof 36
International Journal of Food Microbiology|December 16, 2003
Enhancement of nisin, lysozyme, and monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and lactoferrinJill K Branen, P Michael Davidson
Expert Review of Cardiovascular Therapy|September 27, 2005
Torcetrapib/atorvastatin combination therapyHarold Bays, James McKenney, Michael Davidson
Trends in Cardiovascular Medicine|August 15, 2009
The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitusTamar Polonsky, Theodore Mazzone, Michael Davidson
Journal of Food Protection|March 7, 2013
Antimicrobial activity of nanodispersed thymol in tryptic soy brothBhavini Shah, P Michael Davidson, Qixin Zhong
International Journal of Food Microbiology|December 25, 2012
Nanodispersed eugenol has improved antimicrobial activity against Escherichia coli O157:H7 and Listeria monocytogenes in bovine milkBhavini Shah, P Michael Davidson, Qixin Zhong
Applied and Environmental Microbiology|October 2, 2012
Nanocapsular dispersion of thymol for enhanced dispersibility and increased antimicrobial effectiveness against Escherichia coli O157:H7 and Listeria monocytogenes in model food systemsBhavini Shah, P Michael Davidson, Qixin Zhong
Journal of Clinical Lipidology|March 6, 2012
Polish Lipid Association--a strong response to the problem of lipid disorders in Poland and Central and Eastern EuropeMaciej Banach, Michael Davidson, Peter P Toth
Dialogues in Clinical Neuroscience|October 29, 2011
Treatment-refractory schizophreniaAsaf Caspi, Michael Davidson, Carol A Tamminga
Dialogues in Clinical Neuroscience|October 29, 2011
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?Ramit Ravona-Springer, Michael Davidson, Shlomo Noy
Oncotargets and Therapy|August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinomaMichael Davidson, Elizabeth C Smyth, David Cunningham
Pageof 36